June 12, 2018
Sponsored by
Philips Genomics

Bridging the Gap Between Testing and Treatment in Precision Oncology


Chief Technology Officer, Navican

Chief Technology Officer, Philips Genomics

This webinar highlights a comprehensive end-to-end solution for precision care in oncology, comprising sample acquisition through to sequencing and analysis, treatment recommendations, and follow-through.

Scott Skellenger, chief technology officer of Intermountain Healthcare spinout Navican, discusses the infrastructure Navican has put in place to match patients with prioritized treatment options in order to deliver better outcomes while reducing the overall cost burden on the healthcare system.

Navican's services assist oncologists and their patients throughout the process of acquiring and profiling a tumor sample, reviewing the case and making a prioritized treatment recommendation with the molecular tumor board, facilitating therapy access and appeals, and ongoing patient follow-up.

Navican has partnered with Philips to leverage IntelliSpace Genomics as the hub of its clinical and informatics infrastructure. Scott discusses how Navican is using IntelliSpace Genomics to capture and transform genomic and clinical data in support of providing treatment decisions.

Sponsored by

York University researchers find genomic evidence of inbreeding in the yellow-banded bumblebee, according to Reuters.

In its survey of US adults, the Pew Research Center finds that views on the genetic engineering of animals depend on why it's done.

The Scientist reports agricultural researchers are working on a gene-stacking tool.

In Nature this week: statistical method for overcoming case-control imbalance issues, and more.

Sponsored by

This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.

Sponsored by

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.

Sponsored by
Horizon Discovery

In this webinar, Kevin Balbi, head of bioinformatics at Sarah Cannon Molecular Diagnostics, will discuss the validation of targeted sequencing panels on the Ion Torrent platform using Horizon Discovery’s Tru-Q controls.